Integrin beta 4 (ITGB4) is highly expressed on triple-negative breast cancer (TNBC) cells and their derived exosomes, and promotes glycolysis in CAFs through mitophagy (Sung et al., 2020). This evidence concerns the gene ITGB4 and triple-negative breast carcinoma.